Complex Regional Pain Syndrome Clinical Trials 2023

What are the top hospitals conducting complex regional pain syndrome research?

Complex regional pain syndrome (CRPS) is a debilitating condition that affects a patient's nervous system, causing severe and chronic pain. In the quest for effective treatments and interventions, several top hospitals are leading the way in conducting clinical trials dedicated to CRPS. Stanford University, situated in Palo Alto and Stanford, has emerged as a frontrunner with its ongoing commitment to addressing this complex and challenging disorder. Currently, they have two active trials focused on CRPS, building upon their previous two studies since undertaking their initial trial in 2015. Meanwhile, the University of Washington in Seattle has made notable strides by exclusively offering clinical trials specifically tailored to CRPS patients; their dedication includes an ongoing trial and one previously conducted study starting from 2022.

Furthermore, groundbreaking efforts can be witnessed at the Fralin Biomedical Research Institute located in Roanoke where they are actively pursuing one trial targeting complex regional pain syndrome while also having completed another investigation since initiating research endeavors into this condition just last year—2023.Though relatively new to the field compared to other institutions mentioned here,the UCSF Medical Center based out of San Francisco showcases equal determination with its present-day engagement in an ongoing clinical trial alongside gainful utilization of opportunities provided by their past singular investigations beginning from 2022 onwards.

These hospitals' unwavering dedication towards advancing our understanding of CRPS demonstrates a commitment to improving the lives of those living with this excruciating condition. By pioneering innovative approaches through rigorous scientific investigations,collaborating across specialties,and employing cutting-edge technologies these institutions endeavor not only provide much-needed relief but also strive toward finding long-lasting solutions for a better quality life for individuals battling Complex Regional Pain Syndrome

Which are the best cities for complex regional pain syndrome clinical trials?

When it comes to clinical trials for complex regional pain syndrome, several cities are leading the way in research and treatment options. Palo Alto, California and San Francisco, California both have 2 active trials each, focusing on interventions such as Empowered Relief for Youth, LDN, High Frequency rTMS, Active DBS. Additionally, Stanford University in California has 1 active trial investigating treatments like Ketamine and Midazolam. Seattle in Washington also has 1 ongoing trial exploring Roosevelt "in Clinic VR" + "VR homeworks". Finally, Roanoke in Virginia offers 1 active trial studying LIFU - CRPS. These cities serve as hubs of innovation and provide individuals with complex regional pain syndrome access to cutting-edge clinical trials that offer hope for improved outcomes and relief from their condition.

Which are the top treatments for complex regional pain syndrome being explored in clinical trials?

Clinical trials exploring treatments for complex regional pain syndrome (CRPS) have identified two top contenders. First on the list is Empowered Relief for Youth, which has shown promise in its ongoing trial specifically targeting CRPS. Introduced in 2023, this treatment aims to provide relief and improvement for young patients suffering from this debilitating condition. Another contender making waves is High Frequency rTMS, with an active trial dedicated to investigating its effectiveness against CRPS. This innovative therapy was first listed in 2022 and holds potential as a non-invasive option for managing the symptoms of CRPS. As research progresses, these treatments offer hope for individuals living with the burdensome challenges of CRPS.

What are the most recent clinical trials for complex regional pain syndrome?

In the realm of complex regional pain syndrome (CRPS), recent clinical trials have focused on exploring the potential benefits of ketamine and midazolam. In a Phase 2 trial, these medications are being investigated for their effectiveness in alleviating the symptoms associated with CRPS. By targeting and managing the unique challenges posed by this condition, researchers aim to enhance patient outcomes and provide relief from chronic pain. With ongoing studies delving into innovative treatment approaches, there is hope for improved quality of life for individuals battling CRPS.

What complex regional pain syndrome clinical trials were recently completed?

Recently completed clinical trials have made significant progress in the field of complex regional pain syndrome (CRPS). These trials aimed to enhance our understanding and develop improved treatments for this debilitating condition. One notable trial was sponsored by the National Institute of Neurological Disorders and Stroke, which explored new therapeutic approaches and concluded recently. Another important study, conducted by Johns Hopkins University School of Medicine, examined the effectiveness of a novel intervention technique on CRPS symptoms. These successful advancements offer hope to individuals living with CRPS and highlight the ongoing efforts to find better solutions for managing this challenging condition.